Download video

Intensity Therapeutics AGM 2025 | Oct 22, 2025

No views

Investing 101

8 days ago

Intensity Therapeutics AGM 2025 | Oct 22, 2025

Intensity Therapeutics AGM 2025 | Oct 22, 2025

Intensity Therapeutics AGM 2025 | Oct 22, 2025
7:57
Intensity Therapeutics AGM 2025 | Oct 22, 2025
by Investing 101
Dr. Valeria Santini: Imetelstat Demonstrates Durable Efficacy in the Treatment of LR-MDS
4:45
Dr. Valeria Santini: Imetelstat Demonstrates Durable Efficacy in the Treatment of LR-MDS
by Mediamedic
SF-3-030: A Function-Selective ERK2 Inhibitor for Targeted Cancer Therapy
5:05
SF-3-030: A Function-Selective ERK2 Inhibitor for Targeted Cancer Therapy
by Cell Biology \& Drug Development
AMOT valve leak
2:06
AMOT valve leak
by delmarblue
Current and Potential Pharmacological Targets for Therapeutic Intervention in Head
5:41
Current and Potential Pharmacological Targets for Therapeutic Intervention in Head
by BP International
Updated safety findings of PF-07220060 and endocrine therapy in HR+\/HER2- breast cancer
1:20
Updated safety findings of PF-07220060 and endocrine therapy in HR+\/HER2- breast cancer
by VJOncology
Phase I\/II tral of NKT2152, an HIF-2α inhibitor, in pre-treated accRCC
1:48
Phase I\/II tral of NKT2152, an HIF-2α inhibitor, in pre-treated accRCC
by VJOncology
END029 2 Chemobenefit Case Studies Webinar 1920x1080px V2 c76cn39qjz
51:37
END029 2 Chemobenefit Case Studies Webinar 1920x1080px V2 c76cn39qjz
by Eurobio Scientific Group
An update of IMproveMF: dose-escalation of imetelstat + ruxolitinib in patients with myelofibrosis
2:46
An update of IMproveMF: dose-escalation of imetelstat + ruxolitinib in patients with myelofibrosis
by VJHemOnc – Video Journal of Hematology \& HemOnc